Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
Resmed Inc has filed a notice of proposed sale of securities under Rule 144, indicating the sale of 1,000 common shares valued at approximately $234,040. Brett Sandercock, an officer of the company, plans to sell these shares on the NYSE on January 8, 2025. This announcement follows Sandercock’s recent sales of similar quantities of shares over the past three months, reflecting ongoing transactions that may impact shareholder perceptions and market dynamics.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc operates in the healthcare industry, focusing on providing innovative solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company’s primary products include devices and software applications designed to enhance the quality of life for patients with sleep and respiratory disorders.
YTD Price Performance: 2.12%
Average Trading Volume: 929,006
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.46B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.
